In this free webinar, learn about the rapidly growing cell and gene therapy and vaccine markets. Attendees will get an overview of the manufacturing process for adeno-associated virus (AAV) and how Akron Bio's new facility is designed to address the serious industry issues around capacity, scalability, and quality. The featured speakers will discuss the latest information from regulators on how plasmid DNA (pDNA) quality should be assessed, creating a guideline for manufacturers to work to.
TORONTO, Ontario, Oct. 28, 2022 /PRNewswire-PRWeb/ -- Join this webinar to discuss the growing cell and gene therapy and vaccine markets, the resulting critical bottlenecks in plasmid (pDNA) production, and how these bottlenecks are being addressed by collaborations and partnerships between some of the key contributors to the biomanufacturing supply chain.
The featured speakers will give an overview of the manufacturing process for adeno-associated virus (AAV) and highlight how Akron Bio's new facility is designed to address the serious industry issues around capacity, scalability, and quality. The speakers will discuss the cGMP quality controls and the full suite of pDNA-centered, in-house analytical development, qualification, and validation capabilities. Attendees will learn about full-scale engineering and process validation capabilities enabling cGMP production, completion of clinical trials, and approved therapy commercialization.
Register to learn about meeting the increasing manufacturing demands of the rapidly growing cell and gene therapy and vaccine markets.
Join Ana Martini (webinar moderator), PhD, Associate Director, Program Management, Akron Bio; Andrea O'Hara, PhD, Strategic Technical Specialist, Next-Generation Sequencing, Azenta Life Sciences; Ian Hart, VP of Operations, Akron Bio; and Kurt Herzog, Director of Process Scale-up, AstraZeneca, for the live webinar on Friday, November 11, 2022, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Meeting the Increasing Manufacturing Demands of the Rapidly Growing Cell and Gene Therapy and Vaccine Markets.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article